Cost-effectiveness analysis in heart disease, part II: Preventive therapies
- 28 February 1995
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 37 (4), 243-271
- https://doi.org/10.1016/s0033-0620(05)80009-x
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Gemfibrozil Cost-Benefit StudyDrugs, 1990
- Clinical Decisions in the Management of the CardiomyopathiesDrugs, 1989
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionNew England Journal of Medicine, 1988
- Improvement in Long-Term Survival among Patients Hospitalized with Acute Myocardial Infarction, 1970 to 1980New England Journal of Medicine, 1987
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Free Care, Cholestyramine, and Health PolicyNew England Journal of Medicine, 1984
- Care of Patients with a Low Probability of Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Does Free Care Improve Adults' Health?New England Journal of Medicine, 1983
- The Effects of Group Size on Test Ordering for Hypertensive PatientsNew England Journal of Medicine, 1983
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982